Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03343158Terminated

Orphans and Vulnerable Children Risk Screening Tool Research Study (Zimbabwe)

Role: collaborator

NCT03780348Not ApplicableUnknown

A Novel Low-Cost Tool for a More Efficient and Reliable Weight-for-Height/Length Assessment

Role: lead

NCT02758353Not ApplicableCompleted

The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in Nigeria

Role: lead

NCT02554825Not ApplicableCompleted

Healthy Futures Evaluation

Role: lead

NCT02192125Early Phase 1Completed

REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial

Role: collaborator

All 5 trials loaded